<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interferon-alpha 1 from Escherichia coli transformed with a hybrid plasmid containing a human leukocyte complementary DNA insert, induces resistance to virus in appropriate target cells </plain></SENT>
<SENT sid="1" pm="."><plain>It also shares the following properties with natural leukocyte interferon (IFN) </plain></SENT>
<SENT sid="2" pm="."><plain>(i) It enhances natural killing activity of human lymphocytes, (ii) it enhances antibody-dependent cell-mediated cytotoxicity, (iii) it suppresses antigen- and <z:chebi fb="0" ids="52290">mitogen</z:chebi>-induced leukocyte migration inhibition, (iv) it inhibits growth of IFN-sensitive Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="3" pm="."><plain>Since these activities are exhibited by a cloned protein species, they are due to IFN itself and not to other human proteins </plain></SENT>
</text></document>